Skip to main navigation

The link is opening in a new window or tab that may or may not accessible Opens an external site Opens an external site in a new window

Pre-Header Contact

800-449-3353 | custserv@rockwellmed.com |

Footer Socials

Pre-Header Menu

Careers | Contact Us

Client Header Links

Home
Our Company
Our Therapeutic Focus
Our Technology
Hemodialysis Concentrates
Investors

Investor Relations

Press Releases

Main navigation

Investor Home
Press Releases
Events & Presentations
Corporate Governance
Management
Annual Meeting
Financial Information
Stock Information
Investor FAQs
Contact Us
Shareholder Tools

Press Releases

Year

Sep 14, 2022

Rockwell Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

PDF Version

Sep 07, 2022

Rockwell Medical Names Heather Hunter SVP, Chief Corporate Affairs Officer

PDF Version

Aug 15, 2022

Rockwell Medical Announces Second Quarter 2022 Results

PDF Version

Aug 03, 2022

Rockwell Medical to Release Second Quarter 2022 Financial Results on Monday, August 15

PDF Version

Jun 22, 2022

Rockwell Medical Provides Corporate and Clinical Update

PDF Version

Jun 22, 2022

Rockwell Medical, Inc. Appoints Mark Strobeck, Ph.D., as President and Chief Executive Officer

PDF Version

Jun 07, 2022

Rockwell Medical Closes $15 Million Financing from Leading Healthcare Investor

PDF Version

Jun 01, 2022

Rockwell Medical Regains Compliance with Nasdaq Listing Requirements

PDF Version

May 31, 2022

Rockwell Medical Announces $15 Million At-Market Offering

PDF Version

May 23, 2022

Rockwell Medical, Inc. to Present at H.C. Wainwright Annual Global Life Sciences Conference

PDF Version

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Shareholder Tools

Snapshot

Email Alerts

RSS News Feeds

Have any questions?

Phone 248-432-1362

IR@RockwellMed.com

Client Header Links

Home
Our Company
Our Therapeutic Focus
Our Technology
Hemodialysis Concentrates
Investors
Contact

Footer Socials